Literature DB >> 30628484

MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2.

Ruifeng Zhang1, Hua Su1, Xiuqing Ma1, Xiaoling Xu1, Li Liang1, Guofeng Ma1, Liuhong Shi2.   

Abstract

Angiotensin-converting enzyme 2 (ACE2) protects against hypoxic pulmonary hypertension (HPH) by inhibiting the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs). Under hypoxia, the hypoxia-inducible factor 1α (HIF-1α) inhibits ACE2 indirectly; however, the underlying mechanism is unclear. In the present study, we found that exposure to chronic hypoxia stimulated microRNA (miRNA) let-7b expression in rat lung via a HIF-1α-dependent pathway. Let-7b downregulated ACE2 expression by directly targeting the coding sequence of ACE2. Our in vitro and in vivo results revealed that let-7b contributed to the pathogenesis of HPH by inducing PASMCs proliferation and migration. Let-7b knockout mitigated right ventricle hypertrophy and pulmonary vessel remodeling in HPH by restoring ACE2 expression. Overall, we demonstrated that HIF-1α inhibited ACE2 expression via the HIF-1α-let-7b-ACE2 axis, which contributed to the pathogenesis of HPH by stimulating PASMCs proliferation and migration. Since let-7b knockout alleviated the development of HPH, let-7b may serve as a potential clinical target for the treatment of HPH.

Entities:  

Keywords:  ACE2; HIF-1α; Let-7b; hypoxic pulmonary hypertension; miRNA

Year:  2019        PMID: 30628484     DOI: 10.1152/ajplung.00387.2018

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  24 in total

Review 1.  Hypoxia-inducible factor signaling in pulmonary hypertension.

Authors:  Soni Savai Pullamsetti; Argen Mamazhakypov; Norbert Weissmann; Werner Seeger; Rajkumar Savai
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

2.  Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension.

Authors:  Ravindra K Sharma; Aline C Oliveira; Tao Yang; Marianthi M Karas; Jing Li; Gilberto O Lobaton; Victor P Aquino; Iñaki Robles-Vera; Annette D de Kloet; Eric G Krause; Andrew J Bryant; Amrisha Verma; Qiuhong Li; Elaine M Richards; Mohan K Raizada
Journal:  Hypertension       Date:  2020-05-18       Impact factor: 10.190

3.  Angiotensin-converting enzyme 2 inhibits inflammation and apoptosis in high glucose-stimulated microvascular endothelial cell damage by regulating the JAK2/STAT3 signaling pathway.

Authors:  Yi Ren; Wei Xie; Song Yang; Ying Jiang; Danni Wu; Hao Zhang; Shiying Sheng
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 4.  A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease.

Authors:  Priscilla R Prestes; Michelle C Maier; Bradley A Woods; Fadi J Charchar
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

Review 5.  Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.

Authors:  Soudeh Ghafouri-Fard; Rezvan Noroozi; Mir Davood Omrani; Wojciech Branicki; Ewelina Pośpiech; Arezou Sayad; Krzysztof Pyrc; Paweł P Łabaj; Reza Vafaee; Mohammad Taheri; Marek Sanak
Journal:  Vascul Pharmacol       Date:  2020-05-11       Impact factor: 5.773

6.  Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology.

Authors:  Vinicius Novaes Rocha
Journal:  Med Hypotheses       Date:  2020-10-01       Impact factor: 1.538

Review 7.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 8.  Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19.

Authors:  Rafael Silva Lima; Luiz Paulo Carvalho Rocha; Paula Rocha Moreira
Journal:  Cell Biochem Funct       Date:  2021-06-01       Impact factor: 3.963

Review 9.  Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.

Authors:  Yanwei Li; Wei Zhou; Li Yang; Ran You
Journal:  Pharmacol Res       Date:  2020-04-14       Impact factor: 7.658

10.  Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.

Authors:  Antonio Novelli; Michela Biancolella; Paola Borgiani; Dario Cocciadiferro; Vito Luigi Colona; Maria Rosaria D'Apice; Paola Rogliani; Salvatore Zaffina; Francesca Leonardis; Andrea Campana; Massimiliano Raponi; Massimo Andreoni; Sandro Grelli; Giuseppe Novelli
Journal:  Hum Genomics       Date:  2020-09-11       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.